SARS-CoV-2 infection in patients with β-thalassemia : Experience from Lebanon
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:96 |
|---|---|
| Enthalten in: |
American journal of hematology - 96(2021), 8 vom: 01. Aug., Seite E285-E288 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bou-Fakhredin, Rayan [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
AQK7UBA1LS |
|---|
| Anmerkungen: |
Date Completed 15.07.2021 Date Revised 05.10.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/ajh.26211 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM324682077 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM324682077 | ||
| 003 | DE-627 | ||
| 005 | 20231225190833.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/ajh.26211 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1082.xml |
| 035 | |a (DE-627)NLM324682077 | ||
| 035 | |a (NLM)33914955 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bou-Fakhredin, Rayan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 infection in patients with β-thalassemia |b Experience from Lebanon |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.07.2021 | ||
| 500 | |a Date Revised 05.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Immunoglobulin Fc Fragments |2 NLM | |
| 650 | 7 | |a Iron Chelating Agents |2 NLM | |
| 650 | 7 | |a Phosphodiesterase Inhibitors |2 NLM | |
| 650 | 7 | |a Recombinant Fusion Proteins |2 NLM | |
| 650 | 7 | |a Vitamins |2 NLM | |
| 650 | 7 | |a luspatercept |2 NLM | |
| 650 | 7 | |a AQK7UBA1LS |2 NLM | |
| 650 | 7 | |a Activin Receptors, Type II |2 NLM | |
| 650 | 7 | |a EC 2.7.11.30 |2 NLM | |
| 700 | 1 | |a Daadaa, Hisham |e verfasserin |4 aut | |
| 700 | 1 | |a Koussa, Suzanne |e verfasserin |4 aut | |
| 700 | 1 | |a Abou Nasr, Therese |e verfasserin |4 aut | |
| 700 | 1 | |a Noun, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Taher, Ali T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of hematology |d 1993 |g 96(2021), 8 vom: 01. Aug., Seite E285-E288 |w (DE-627)NLM000124354 |x 1096-8652 |7 nnns |
| 773 | 1 | 8 | |g volume:96 |g year:2021 |g number:8 |g day:01 |g month:08 |g pages:E285-E288 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/ajh.26211 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 96 |j 2021 |e 8 |b 01 |c 08 |h E285-E288 | ||